Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
A side-by-side editorial comparison of ManageEngine RecoveryManager Plus and r2rtf — release velocity, themes, recent moves, and the top alternatives to consider.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
RecoveryManager Plus is a backup-and-recovery tool for Active Directory and Microsoft 365, and it is the most feature-active of the ManageEngine set here. Recent builds add real backup coverage — AD sites and subnets, Entra ID local admin passwords, S3-compatible repositories, SIEM audit forwarding, and Entra ID BitLocker recovery keys — alongside CVE patches and RemCom agent hardening. Build 6322 is the quietest of the run: a single fix for restarts triggered by an outdated ExchangeOnlineManagement PowerShell module during Microsoft 365 enumeration.
Read the full ManageEngine RecoveryManager Plus trajectory →
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
r2rtf builds the RTF tables, listings and figures that go into clinical study reports, and its recent releases have been about widening who and what it can serve rather than changing how tables are composed. The 1.2.0 release added internationalization — a SimSun font path for Chinese characters plus hyphenation control — and 1.3.0 followed with write_docx() and write_html(), turning the LibreOffice conversion the package had documented into exported functions.
RecoveryManager Plus is a backup-and-recovery tool for Active Directory and Microsoft 365, and it is the most feature-active of the ManageEngine set here. Recent builds add real backup coverage — AD sites and subnets, Entra ID local admin passwords, S3-compatible repositories, SIEM audit forwarding, and Entra ID BitLocker recovery keys — alongside CVE patches and RemCom agent hardening. Build 6322 is the quietest of the run: a single fix for restarts triggered by an outdated ExchangeOnlineManagement PowerShell module during Microsoft 365 enumeration.
The direction is coverage expansion: methodically extending what can be backed up and restored across on-prem AD and Entra ID, while broadening cloud storage targets and operational integrations. The dependence on Microsoft's own PowerShell modules is the cost of that coverage, and 6322 shows where it bites — a stale module on the customer's side takes the product down mid-enumeration. Feature builds and pure-fix builds alternate at roughly a two-month cadence, so a single-issue build reads as a gap between feature cycles rather than a slowdown.
Expect continued expansion of Entra ID and cloud-native backup coverage and more storage-target options, with security patches folded into each build; the next build carrying a Features section is due on the cadence this feed has held.
r2rtf builds the RTF tables, listings and figures that go into clinical study reports, and its recent releases have been about widening who and what it can serve rather than changing how tables are composed. The 1.2.0 release added internationalization — a SimSun font path for Chinese characters plus hyphenation control — and 1.3.0 followed with write_docx() and write_html(), turning the LibreOffice conversion the package had documented into exported functions.
Two threads run through the window. One is output reach: RTF remains the composition target, but the artifacts that come out of it now include DOCX and HTML, and page numbering can be made table-relative across multi-page tables. The other is durability under a moving R and font stack — the ANSI/Unicode converter was rebuilt, the LaTeX mapping table generated from code rather than shipped as sysdata, unlist() usage fixed for R 4.5, and graphics-device leaks that produced stray Rplots.pdf closed off.
Having exported DOCX and HTML conversion, the likely next step is filling in what those formats lose relative to RTF — pagination and footnote fidelity are the obvious gaps. The i18n path currently covers Chinese only, so additional font families are the other plausible direction.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ManageEngine RecoveryManager Plus or r2rtf.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all ManageEngine RecoveryManager Plus alternatives → · See all r2rtf alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. ManageEngine RecoveryManager Plus is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ManageEngine RecoveryManager Plus is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top ManageEngine RecoveryManager Plus alternatives in Analytics are ranked by recent ship velocity. Browse the "ManageEngine RecoveryManager Plus alternatives" section above for the current picks, or visit /alternatives/manageengine-recoverymanager-plus for the full list with editorial commentary on each.
Top r2rtf alternatives in Analytics are ranked by recent ship velocity. Browse the "r2rtf alternatives" section above for the current picks, or visit /alternatives/r2rtf for the full list with editorial commentary on each.